We are sorry to announce that Lynkos will be shut off on 1st September. You can export your data by going to each section and selecting the export link in the options button on the right.
Sorry for the inconvenience and thank you for having been part of our story!

About Us

Opthea Pty Ltd is a private, 100% owned subsidiary of Circadian Technologies Limited based in Melbourne, Australia.

Opthea is developing novel biologic inhibitors of angiogenesis (blood vessel growth), lymphangiogenesis (lymphatic vessel growth) and vascular leakage for the treatment of ophthalmic diseases.

Opthea has received seed funding from Circadian Technologies and is actively seeking partnership opportunities and investment for its development programs. Enquiries can be directed to: info@opthea.com

Industry

Business size

26-100 employees

Keywords

Commercial presence